Pharma GCCs vs General-Purpose GCCs: What Really Sets Them Apart?

In this episode of the “GenAI-Powered GCCs for the Future of Pharma” series, Tarun Mathur, Chief Technology Officer at Indegene, is joined by Emmanuel Puginier, a global expert in pharma delivery center strategy. Together, they explore how pharma Global Capability Centers (GCCs) differ from general-purpose GCCs—and why that distinction matters more than ever in the age of Generative AI.

Key Topics Covered:

• Why regulatory complexity and scientific depth set pharma GCCs apart
• The shift from efficiency-focused to innovation-driven global hubs
• How GenAI is reshaping operations, workflows, and talent requirements

Whether you are a pharma leader, GCC strategist, or digital transformation professional, this series will help you understand how to build and scale next-generation pharma GCCs.

Don’t miss the next episode, where we dive into how GenAI is transforming global pharma workflows.